Indus Capital Partners, LLC Hutchmed (China) LTD Transaction History

Indus Capital Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$23.7 - $39.27 $487,106 - $807,116	-20,553 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$27.01 - $36.8 $555,136 - $756,350	20,553 New	20,553 $581,000
Q3 2019 Nov 14, 2019	SELL	$17.84 - $22.69 $1.25 Million - $1.59 Million	-70,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.0 - $31.78 $1.54 Million - $2.22 Million	70,000 New	70,000 $1.54 Million
Q3 2018 Nov 14, 2018	SELL	$26.55 - $34.38 $658,440 - $852,624	-24,800 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$27.41 - $39.42 $68,525 - $98,550	2,500 Added 11.21%	24,800 $978,000
Q3 2017 Nov 14, 2017	BUY	$22.15 - $27.5 $493,944 - $613,250	22,300	22,300 $608,000

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Indus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indus Capital Partners, LLC with notifications on news.